Gov. Gavin Newsom will seek to regulate pharmaceutical middlemen that he blames for driving up prescription drug costs in ...

Trump’s first-term rule—“Most Favored Nation”—was focused on lowering the cost of Medicare payments on certain drugs, but it ...

Byrnes, a Republican, represented Worth, Mitchell and Howard counties and part of Winneshiek County in the Iowa House and was ...

The pharmaceutical industry, which is well known for its well-resourced lobbying campaigns, has a lesser-known tactic for influencing policy: bankrolling ostensibly independent nonprofit organizations ...

Mike Nesbitt says it would have been "unfair" to leave health employers to bear the brunt of the extra costs.

The Iowa House approved a bill Monday that would place limits on pharmacy benefit managers, which function as intermediaries between insurance providers and drug manufacturers.

CT officials and providers warned federal Medicaid cuts outlined in a Congressional Republican plan would have devastating ...

While Big Pharma seems ready to weather the tariff storm, independent pharmacists and makers of generic drugs — which account ...

Pharmacy benefit managers would face a range of new requirements under a bill heading to Gov. Kim Reynolds' desk.

Welcome back to Diagnosis, a vertical that focuses on the crossroads of health care policy and politics. ___ — Heart bill to ...

A recent NHS-commissioned independent economic analysis of pharmacy finances, carried out before the Government’s funding ...